BioSpace News Archive

Stimlabs LLC, (“StimLabs”), a leader in regenerative medicine, announced the launch of Relese, a fenestrated dehydrated complete human placental membrane (dCHPM) allograft for chronic and acute wounds.

Tarsus Pharmaceuticals, Inc., whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announced that XDEMVY™ 0.25% is now available at pharmacies nationwide for prescription.

Lucid Diagnostics Inc. a commercial-stage, cancer prevention medical diagnostics company and majority-owned subsidiary of PAVmed Inc., announced that the Company has contracted with the Ancira Auto Group, a premier auto dealer serving South Texas, to offer EsoGuard® esophageal precancer testing to eligible employees across all twelve of its locations in San Antonio and surrounding areas.

Cutera, Inc. is pleased to announce the appointment of Jeff Jones as Chief Operating Officer, effective August 28, 2023.

August 23, 2023) - American Aires Inc. (CSE: WIFI) (OTC Pink: AAIRF) (“Aires” or the “Company”), a leader in scientifically-proven EMF modulation technology

US Digestive Health, one of the largest gastroenterology practices in the United States, announced the addition of nine physicians this summer to its continuously expanding footprint.

The Foundation for the National Institutes of Health has awarded its sixth annual Trailblazer Prize for Clinician-Scientists to Vinod Balachandran, M.D., at Memorial Sloan Kettering Cancer Center, for his groundbreaking research on immunotherapies for pancreatic cancer.

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for ABRYSVO™, the company’s bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) vaccine, to help protect both infants through maternal immunization and older adults.

Alafair Biosciences announced that it has been recognized as No. 1249 on the 2023 Inc. 5000, the annual list of the fastest-growing private companies in America, and No. 23 among Health Products.

Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced today that Mark Pomeranz, President and Chief Executive Officer, will present at the H.C. Wainwright 25th Annual Global Investment Conference.